MaxCyte is headquartered in Rockville, Maryland.
MaxCyte disclosed revenue of 39M USD for 2024 and 41M USD for 2023.
MaxCyte has 114 employees.
MaxCyte is a life science company.
MaxCyte was founded in 1998.
9713 Key West Avenue Suite 400,
Rockville, Maryland
20850
United States,
(301) 944-1700
www.maxcyte.com
MaxCyte discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. MaxCyte was founded in 1998 and is headquartered in Rockville, Maryland.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | - | - | - | - | 1 | 1 |
| vol | $5M | $5M | ||||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
